Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Price:
83.5
EUR
3.99%
Market Closed
Market Cap:
€4.3B
Relative Value
The Relative Value of one
ROVI
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 83.5 EUR,
Laboratorios Farmaceuticos ROVI SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ROVI Relative Value
HIDDEN
Multiples Across Competitors
ROVI Competitors Multiples
Laboratorios Farmaceuticos ROVI SA Competitors
Laboratorios Farmaceuticos ROVI SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
|
4.3B EUR | 5.7 | 30.4 | 19.7 | 23 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
946.1B USD | 14.5 | 45.8 | 30.9 | 33 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.8B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
267.4B CHF | 4.3 | 20.8 | 12.2 | 13.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
226.4B GBP | 5.2 | 29.7 | 16.4 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
234.9B CHF | 5.4 | 21.6 | 13.4 | 17.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
289.8B USD | 4.5 | 15.9 | 9.9 | 12 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121B USD | 2.5 | 17.2 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
